Vis enkel innførsel

dc.contributor.authorBurton, Joshua
dc.contributor.authorUmu, Sinan Uğur
dc.contributor.authorLangseth, Hilde
dc.contributor.authorGrotmol, Tom
dc.contributor.authorGrimsrud, Tom Kristian
dc.contributor.authorHaugen, Trine B.
dc.contributor.authorRounge, Trine Ballestad
dc.date.accessioned2021-05-25T13:13:58Z
dc.date.available2021-05-25T13:13:58Z
dc.date.created2020-09-23T15:30:40Z
dc.date.issued2020-10-28
dc.identifier.citationFrontiers in Oncology. 2020, 10, (1-13).en_US
dc.identifier.issn2234-943X
dc.identifier.urihttps://hdl.handle.net/11250/2756335
dc.description.abstractAlthough testicular germ cell tumor (TGCT) overall is highly curable, patients may experience late effects after treatment. An increased understanding of the mechanisms behind the development of TGCT may pave the way for better outcome for patients. To elucidate molecular changes prior to TGCT diagnosis we sequenced small RNAs in serum from 69 patients who were later diagnosed with TGCT and 111 matched controls. The deep RNA profiles, with on average 18 million sequences per sample, comprised of nine classes of RNA, including microRNA. We found that circulating RNA signals differed significantly between cases and controls regardless of time to diagnosis. Different levels of TSIX related to X-chromosome inactivation and TEX101 involved in spermatozoa production are among the interesting findings. The RNA signals differed between seminoma and non-seminoma TGCT subtypes, with seminoma cases showing lower levels of RNAs and non-seminoma cases showing higher levels of RNAs, compared with controls. The differentially expressed RNAs were typically associated with cancer related pathways. Our results indicate that circulating RNA profiles change during TGCT development according to histology and may be useful for early detection of this tumor type.en_US
dc.description.sponsorshipInternal funds of OsloMet—Oslo Metropolitan University and Cancer Registry of Norway.en_US
dc.language.isoengen_US
dc.publisherFrontiers Mediaen_US
dc.relation.ispartofseriesFrontiers in Oncology;volume 10
dc.rightsNavngivelse 4.0 Internasjonal*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/deed.no*
dc.subjectRNA profilingen_US
dc.subjectSerumen_US
dc.subjectTesticular canceren_US
dc.subjectSeminomaen_US
dc.subjectNon-seminomaen_US
dc.subjectSequencingen_US
dc.subjectmiRNAen_US
dc.titleSerum RNA profiling in the 10-year period prior to diagnosis of testicular germ cell tumouren_US
dc.typePeer revieweden_US
dc.typeJournal articleen_US
dc.description.versionpublishedVersionen_US
dc.rights.holderCopyright © 2020 Burton, Umu, Langseth, Grotmol, Grimsrud, Haugen and Rounge.en_US
dc.source.articlenumber574977en_US
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1
dc.identifier.doihttps://doi.org/10.3389/fonc.2020.574977
dc.identifier.cristin1832663
dc.source.journalFrontiers in Oncologyen_US
dc.source.volume10en_US
dc.source.pagenumber1-13en_US
dc.relation.projectNorges forskningsråd: 229621/H10en_US
dc.relation.projectNorges forskningsråd: 248791/H10en_US


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel

Navngivelse 4.0 Internasjonal
Med mindre annet er angitt, så er denne innførselen lisensiert som Navngivelse 4.0 Internasjonal